Biomarkers and the prediction of atrial fibrillation: state of the art
Open Access
- 1 July 2016
- journal article
- review article
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 12, 297-303
Abstract
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, and it places a substantial burden on the health care system. Despite improvements in our understanding of AF pathophysiology, we have yet to develop targeted preventive therapies. Recently, numerous biological markers have been identified to aid in the prediction of future AF events. Subclinical markers of atrial stress, inflammation, endothelial dysfunction, kidney dysfunction, and atherosclerosis have been linked to AF. The connection between these markers and AF is the identification of subclinical states in which AF propagation is likely to occur, as these conditions are associated with abnormal atrial remodeling and fibrosis. Additionally, several risk scores have been developed to aid in the identification of at-risk patients. The practicing clinician should be aware of these subclinical markers, as several of these markers improve the predictive abilities of current AF risk scores. Knowledge of these subclinical markers also provides clinicians with a better understanding of AF risk factors, and the opportunity to reduce the occurrence of AF by incorporating well-known cardiovascular disease risk factor modification strategies. In this review, we highlight several novel biological markers that have improved our understanding of AF pathophysiology and appraise the utility of these markers to improve our ability to predict future AF events.Keywords
This publication has 78 references indexed in Scilit:
- Peripheral Arterial Disease and Risk of Atrial Fibrillation and Stroke: The Multi‐Ethnic Study of AtherosclerosisJournal of the American Heart Association, 2014
- Brachial Flow-Mediated Dilation and Incident Atrial FibrillationArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Inflammatory Biomarkers as Risk Factors for Future Atrial Fibrillation. An Eleven-Year Follow-Up of 6315 Men and Women: The Tromsø StudyGender Medicine, 2012
- Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patientsJournal Of Hypertension, 2010
- N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial FibrillationCirculation, 2009
- Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine studyAmerican Heart Journal, 2009
- Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation:Thrombosis Research, 2008
- Influence of a Lipid-Lowering Therapy on Calcified and Noncalcified Coronary Plaques Monitored by Multislice Detector Computed TomographyInvestigative Radiology, 2007
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992